Despite overall progress, low birthweight rates still high in certain Indian states

Uttar Pradesh, Bihar, Maharashtra, West Bengal account for almost half of all such births Despite overall progress in bringing down low birthweight numbers across India over the past 30 years, rates remain stubbornly high in certain states, with Uttar Pradesh, Bihar, Maharashtra, and West Bengal, accounting for almost half of ...

2025-06-17T11:26:06+00:0017 June 2025|BMJ Global Health, Press release|

Prolonged use of desogestrel pill linked to small increased brain tumour risk

Although risk much lower than some other progestogens and disappeared one year after stopping treatment Taking the progestogen-only contraceptive pill desogestrel continuously for more than five years is associated with a small increased risk of developing a type of brain tumour called an intracranial meningioma, finds a study from France ...

2025-06-12T10:53:44+00:0012 June 2025|Press release, The BMJ|

Humanising health: conflict, equity, and resilience

Podcasts Analysis Opinion Recordings Meeting report World Health Innovation Summit (WISH) 2024 BMJ Group partnered with the Qatar Foundation to support the World Health Innovation Summit (WISH) 2024, a leading global health event that brings together policymakers, researchers, and healthcare professionals. ...

Over half of doctors surveyed would consider assisted dying if they had advanced cancer or Alzheimer’s disease

And they mostly prefer symptom relief at end of life rather than prolongation of life But preferences vary according to their jurisdiction’s legislation on assisted dying When it comes to advanced cancer or Alzheimer’s disease, over half of doctors would consider assisted dying for themselves, but preferences seem to vary ...

2025-06-11T10:23:56+00:0011 June 2025|Journal of Medical Ethics, Press release|

P2Y12 drugs may be better than aspirin to prevent heart attack and stroke in patients with coronary artery disease

Findings support use of P2Y12 therapy instead of aspirin for long term prevention Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of cardiovascular death, heart attack and stroke compared with traditional aspirin, with no increased risk of major bleeding, finds a ...

2025-06-06T11:31:20+00:006 June 2025|Press release, The BMJ|
Go to Top